MedTrace Logo

The Effects of Beta-glucan Enriched Oatcake Consumption on Metabolic Disease Risk Factors

NCT02615444 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2016-09-27

No results posted yet for this study

Summary

The purpose of this study is to determine whether daily consumption of soluble fibre, oat beta glucan (4g), for six weeks will have any impact on overweight/obese individuals in terms of risk factors used to define metabolic disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Beta-glucan enriched oatcake

5 oatcakes enriched with oat beta-glucan will be consumed daily for six weeks

DIETARY_SUPPLEMENT

Isocaloric control

6.5 wheat based control snacks without beta-glucan will be consumed daily for six weeks

Sponsors & Collaborators

  • Queen Margaret University

    lead OTHER

Principal Investigators

  • Suzanne Zaremba · Queen Margaret University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02615444 on ClinicalTrials.gov